Skip to main content
. 2022 Feb 25;31(14):2452–2461. doi: 10.1093/hmg/ddac024

Table 2.

Significant associations of rs11385942, rs74956615 and rs657152 with plasma proteins among 1671 Black and 7241 white ARIC participants (top 20 for white participants shown for rs657152)

White participants Protein Black participants Protein
Variant Protein Estimate* (95% CI) P-value SD Estimate* (95% CI) P-value SD
rs657152 ABO system transferase 2.85 (2.79, 2.92) <1.0E-300 2.71 2.13 (1.96, 2.30) 2.2E-109 2.89
DC-SIGN 0.33 (0.32, 0.35) <1.0E-300 0.50 0.24 (0.21, 0.28) 2.2E-36 0.55
Sulfhydryl oxidase 2 0.23 (0.22, 0.24) 1.2E-299 0.38 0.10 (0.07, 0.12) 5.0E-15 0.36
Protein FAM3D 0.46 (0.44, 0.49) 9.9E-251 0.82 0.16 (0.11, 0.21) 1.4E-10 0.74
E-selectin −0.28 (−0.29, −0.26) 1.9E-223 0.52 −0.14 (−0.18, −0.11) 9.4E-18 0.48
D-glucuronyl C5-epimerase 0.14 (0.13, 0.15) 2.6E-175 0.32 0.05 (0.03, 0.07) 6.6E-06 0.32
Golgi membrane protein 1 0.25 (0.23, 0.27) 8.1E-144 0.45 0.09 (0.05, 0.12) 4.9E-07 0.52
Golgi membrane protein 1 0.19 (0.18, 0.20) 2.4E-134 0.62 0.10 (0.06, 0.14) 1.8E-06 0.66
Platelet glycoprotein 4 0.19 (0.18, 0.21) 2.4E-109 0.53 0.17 (0.12, 0.22) 2.8E-10 0.95
Protein CASC4 0.09 (0.08, 0.10) 1.1E-86 0.26 0.04 (0.02, 0.05) 6.4E-06 0.29
sTie-1 0.09 (0.08, 0.10) 2.9E-85 0.27 0.13 (0.11, 0.16) 3.9E-30 0.33
Coagulation factor VIII 0.18 (0.16, 0.19) 3.8E-81 0.54 0.16 (0.12, 0.20) 1.3E-16 0.55
C1GALT1-specific chaperone 1 0.06 (0.06, 0.07) 3.2E-79 0.24 0.02 (0.01, 0.03) 2.4E-03 0.20
* * Plexin-D1 −0.09 (−0.10, −0.08) 3.1E-76 0.43 −0.001 (−0.03, 0.02) 9.7E-01 0.43
THSD1 −0.08 (−0.09, −0.07) 2.6E-65 0.29 −0.02 (−0.04, −0.001) 3.5E-02 0.27
Insulin receptor −0.11 (−0.12, −0.10) 2.7E-65 0.37 −0.03 (−0.06, −0.003) 2.9E-02 0.39
* * IL-3 receptor subunit alpha −0.13 (−0.14, −0.11) 4.4E-63 0.47 0.02 (−0.008, 0.05) 1.5E-01 0.50
P-selectin −0.10 (−0.11, −0.09) 5.4E-59 0.37 −0.05 (−0.08, −0.03) 6.9E-05 0.37
VEGF receptor 2 −0.07 (−0.07, −0.06) 1.7E-56 0.24 −0.02 (−0.04, −0.003) 1.9E-02 0.25
LRC-32 0.07 (0.06, 0.08) 2.2E-56 0.29 0.06 (0.04, 0.08) 3.9E-09 0.32
rs74956615 ICAM-5 −0.30 (−0.33, −0.27) 1.4E-77 0.42 −0.31 (−0.49, −0.14) 5.2E-04 0.45
ICAM-5 −0.30 (−0.32, −0.26) 2.2E-70 0.43 −0.30 (−0.48, 0.12) 8.6E-04 0.48
ICAM-1 0.25 (0.21, 0.29) 7.3E-34 0.53 0.18 (0.01, 0.36) 4.1E-02 0.45
rs11385942 * * TDGF-1 0.26 (0.19, 0.34) 6.1E-13 1.21 −0.02 (−0.15, 0.10) 7.3E-1 0.84
High TDGF-1 0.04 (0.00, 0.08) 2.6E-02 0.02 (−0.17, 0.20) 8.7E-1
Low TDGF-1 0.01 (−0.01, 0.03) 3.3E-01 0.01 (−0.04, 0.05) 8.0E-1

Model: General linear regression model adjusted for age, sex, field center, 10 principal components of ancestry and eGFR. Bonferroni correction for multiple testing in white participants, significant associations at P < 1.71E-6. Replication in Black participants for the 84 proteins identified in white participants stipulated a multiple testing corrected threshold of P < 5.95E-4.

*Change in log2 protein associated with one copy increment of at-risk allele for severe COVID-19, e.g. each copy of the rs657152 risk allele was associated with a 2.85 log2 greater ABO system transferase.

* * Variant protein associations that were not replicated in Black participant sample.

ICAM-5 levels were determined by two different DNA aptamers (Supplementary Material, Table S1).

ICAM = intercellular adhesion molecule; DC-SIGN=Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin; sTie-1 = Soluble tyrosine-protein kinase receptor Tie-1, THSD1 = Thrombospondin type-1 domain-containing protein; IL = Interleukin; VEGF=Vascular endothelial growth factor; LRC-32 = Leucine-rich repeat-containing protein 32